{
  "meta": {
    "title": "31_Antimalarial_Drugs",
    "url": "https://brainandscalpel.vercel.app/31-antimalarial-drugs-9b3d4499.html",
    "scrapedAt": "2025-11-30T12:34:17.864Z"
  },
  "questions": [
    {
      "text": "Which of the following antimalarial drugs is a slow acting schizonticide?",
      "choices": [
        {
          "id": 1,
          "text": "Artemether"
        },
        {
          "id": 2,
          "text": "Mefloquine"
        },
        {
          "id": 3,
          "text": "Pyrimethamine"
        },
        {
          "id": 4,
          "text": "Quinine"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Pyrimethamine</strong> is a slow-acting&nbsp;schizonticide.</p>\n<p>Female Anopheles mosquito inoculates <em>Plasmodium</em> species in the form of <strong>sporozoites </strong>into the human host during blood meal. Sporozoites migrate to the liver and mature into hepatic schizonts.<strong> Hepatic schizonts</strong> are released into the blood in the form of&nbsp;<strong>merozoites</strong>. Merozoites in the erythrocyte transform into ring form and <strong>erythrocytic schizonts</strong>. Some merozoites in the blood transform into <strong>gametocytes</strong>.&nbsp;</p>\n<p>Antimalarial drugs are classified based on their onset of action of schizonticidal function as below:</p>\n<ul>\n<li>Fast onset of action&nbsp;\n<ul>\n<li><strong>Artemisinin derivatives</strong> like artemether , arteether and&nbsp; artesunate are<strong>&nbsp;fastest acting</strong></li>\n<li>Chloroquine</li>\n</ul>\n</li>\n<li>Intermediate onset of action\n<ul>\n<li><strong>Mefloquine</strong></li>\n<li><strong>Quinine</strong></li>\n<li>Proguanil</li>\n<li>Lumefantrine</li>\n</ul>\n</li>\n<li>Slow onset of action\n<ul>\n<li>Pyrimethamine</li>\n<li>Sulfonamides</li>\n<li>Tetracyclines</li>\n<li>Clindamycin</li>\n</ul>\n</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/698602ccedb94870a59715ab1e30d06fx1280x1621.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB4845",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is gametocidal to all the species causing malaria?",
      "choices": [
        {
          "id": 1,
          "text": "Primaquine"
        },
        {
          "id": 2,
          "text": "Chloroquine"
        },
        {
          "id": 3,
          "text": "Quinine"
        },
        {
          "id": 4,
          "text": "None"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Primaquine</strong> is <strong>gametocidal</strong> <strong>to all species</strong> causing malaria. It inhibits transmission of malaria.</p>\n<p>The drugs with clinically important gametocidal activity (against all species) are:</p>\n<ul>\n<li>High activity:\n<ul>\n<li>Artemisinins</li>\n<li>Primaquine</li>\n</ul>\n</li>\n<li>Low to moderate activity:\n<ul>\n<li>Chloroquine</li>\n<li>Quinine</li>\n<li>Atovaquone/proguanil</li>\n</ul>\n</li>\n<li>No activity:\n<ul>\n<li>Mefloquine</li>\n<li>Pyrimethamine</li>\n<li>Sulfadoxine</li>\n<li>Tetracycline</li>\n</ul>\n</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/0735275b88fc4d678851ba62673b565ex1280x1621.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC7015",
      "difficulty": "easy"
    },
    {
      "text": "A researcher who was studying plasmodium species decided to visit a malaria-endemic place in Odisha to do his clinical study for 5 weeks. He is planning to leave after 2 days.  Which of the following drugs can be taken as prophylaxis before visiting the malaria-endemic place?",
      "choices": [
        {
          "id": 1,
          "text": "Artesunate"
        },
        {
          "id": 2,
          "text": "Mefloquine"
        },
        {
          "id": 3,
          "text": "Doxycycline"
        },
        {
          "id": 4,
          "text": "Chloramphenicol"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Doxycycline</strong> can be taken as prophylaxis by the researcher before going to malaria-endemic places.</p>\n<p>Chemoprophylaxis against malaria for travelers:</p>\n<ul>\n<li>If the duration of travel is <strong>less than 6 weeks</strong> then <strong>doxycycline 100mg once a day</strong>&nbsp;is to be started <strong>2 days before</strong> travel and continued atleast 4 weeks after travel.</li>\n<li>If the duration of travel is<strong> more than 6 weeks</strong> then <strong>mefloquine 250mg once a week</strong>&nbsp;is to be started <strong>2 weeks before</strong> travel&nbsp;and continued atleast 4 weeks after travel.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD1274",
      "difficulty": "medium"
    },
    {
      "text": "A 35-year-old woman presented with fever and chills. Peripheral blood smear revealed findings suggestive of P. vivax malaria. Which among the following is the most appropriate drug for this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Chloroquine"
        },
        {
          "id": 2,
          "text": "Primaquine"
        },
        {
          "id": 3,
          "text": "Sulfadoxine-pyrimethamine"
        },
        {
          "id": 4,
          "text": "Artesunate"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Most approproate drug for the treatment of malaria due to<strong><em> P. vivax</em></strong>&nbsp;is <strong>chloroquine</strong>.</p>\n<p><em>P. vivax</em> treatment recommendations are:</p>\n<ul>\n<li>Chloroquine-susceptible infections: Chloroquine or artemisinin-based combination therapy (ACT).</li>\n<li>Chloroquine-resistant infections: ACT is the drug of choice but quinine is used during 1st trimester of pregnancy.</li>\n</ul>\n<p>In the absence of resistance data in the question, chloroquine appears to be the most appropriate answer.</p><hr><h3>Related Pearl: Treatment of Malaria</h3><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td>\n<p><strong> Drug of Choice</strong></p>\n</td>\n<td>\n<p><strong>&nbsp;Primaquine Dose</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>P. vivax malaria </strong></p>\n</td>\n<td>\n<p><strong>Chloroquine</strong> 25 mg/kg divided as:</p>\n<p>10mg/kg on day 1</p>\n<p>10mg/kg on day 2</p>\n<p>5mg/kg on day 3</p>\n</td>\n<td>\n<p>0.25 mg/kg for 14 days</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>P. falciparum malaria</strong></p>\n<p>North East</p>\n<p>In other states</p>\n</td>\n<td>\n<p>&nbsp;</p>\n<p><strong>ACT-AL</strong> for 3 days</p>\n<p><strong>ACT-SP</strong> for 3 days&nbsp;</p>\n</td>\n<td>\n<p>&nbsp;</p>\n<p>0.75mg/kg on day 2</p>\n<p>0.75mg/kg on day 2</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Mixed infection</strong></p>\n<p>North East</p>\n<p>In other states</p>\n</td>\n<td>\n<p><strong>ACT-AL</strong> for 3 days</p>\n<p><strong>ACT-SP</strong> for 3 days</p>\n</td>\n<td>\n<p>&nbsp;</p>\n<p>0.25 mg/kg for 14 days</p>\n<p>0.25 mg/kg for 14 days</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Resistance to ACT/ Severe malaria </strong></p>\n</td>\n<td>\n<p>&nbsp;</p>\n<p><strong>Quinine </strong></p>\n</td>\n<td>\n<p>&nbsp;</p>\n<p><strong> -</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Pregnancy</strong></p>\n<p><strong>P. vivax</strong></p>\n</td>\n<td>\n<p><strong>Chloroquine </strong></p>\n</td>\n<td>\n<p><strong>Contraindicated</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Pregnancy</strong></p>\n<p><strong>P. falciparum</strong></p>\n</td>\n<td>\n<p>1<sup>st&nbsp;</sup>trimester: <strong>Quinine</strong></p>\n<p>2<sup>nd</sup> and 3<sup>rd</sup> trimester<strong>: Area specific ACT</strong></p>\n</td>\n<td>\n<p>&nbsp;</p>\n<p><strong>Contraindicated</strong></p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><strong>ACT:&nbsp;</strong>artemisinin-based combination therapy</p>\n<p><strong>AL:</strong>&nbsp;artemether-lumefantrine</p>\n<p><strong>SP</strong>: Sulfadoxine-<wbr />Pyrimethamine</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB4898",
      "difficulty": "medium"
    },
    {
      "text": "Radical cure is required for malaria caused by which of the following species?",
      "choices": [
        {
          "id": 1,
          "text": "P. falciparum and P. vivax"
        },
        {
          "id": 2,
          "text": "P. falciparum and P. malariae"
        },
        {
          "id": 3,
          "text": "P. vivax and P. malariae"
        },
        {
          "id": 4,
          "text": "P. vivax and P. ovale"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Radical cure</strong> is required for malaria caused by <strong>P. vivax</strong> and <strong>P. ovale</strong>.</p>\n<p>In case of <em>Plasmodium vivax</em> and <em>Plasmodium ovale</em>, malarial parasites have an <strong>exoerythrocytic stage (hypnozoites)</strong>. In the exoerythrocytic phase malarial parasites are found in the liver that can cause <strong>relapse</strong> of malaria after clinical cure.</p>\n<p>Therefore, they require <strong>radical cure</strong> by drugs acting on the exoerythrocytic stage.&nbsp;<strong>Primaquine </strong>is effective <strong>against </strong>the exoerythrocytic stages of <em>Plasmodium vivax </em>and<em> Plasmodium ovale</em><strong>&nbsp;</strong>in the liver.&nbsp;Primaquine is administered for 14 days for radical cure.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB4867",
      "difficulty": "medium"
    },
    {
      "text": "Tafenoquine is used in which of the following conditions?",
      "choices": [
        {
          "id": 1,
          "text": "Radical cure of plasmodium vivax"
        },
        {
          "id": 2,
          "text": "Prophylaxis of malaria in pregnancy"
        },
        {
          "id": 3,
          "text": "Treatment of severe falciparum malaria"
        },
        {
          "id": 4,
          "text": "Treatment of malaria in children <2 years"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Tafenoquine</strong> is used in the <strong>radical cure of Plasmodium vivax</strong>. Total eradication of plasmodium species which includes clinical curative and hypnozoites phase are called radical cure.</p>\n<p>Primaquine and tafenoquine (derivative of primaquine) have very high activity against the <strong>latent tissue forms (hypnozoites)</strong> of the species. It is primarily used for the&nbsp;chemoprophylaxis and radical cure of P. vivax and P. ovale&nbsp;infections.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD0139",
      "difficulty": "medium"
    },
    {
      "text": "Chloroquine is not useful in the treatment of which of the following conditions?",
      "choices": [
        {
          "id": 1,
          "text": "Systemic lupus erythematosus"
        },
        {
          "id": 2,
          "text": "Porphyria cutanea tarda"
        },
        {
          "id": 3,
          "text": "Giardiasis"
        },
        {
          "id": 4,
          "text": "Sjogren's Syndrome"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Chloroquine is used in the treatment of systemic lupus erythematosus, porphyria cutanea tarda and giardiasis, due to its <strong>anti-inflammatory effect</strong>; but it is not used in the treatment of&nbsp;Sjogren's Syndrome.</p>\n<p><strong>Chloroquine and hydroxychloroquine </strong>concentrate in lysosomes and have an anti-inflammatory effect. It also has antihistaminic<strong>&nbsp;</strong>and antiarrhythmic properties<strong>.</strong></p>\n<div class=\"page\" title=\"Page 897\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Non-antimalarial uses of <strong>choloroquine</strong> are:</p>\n<ul>\n<li>Hepatic amoebiasis</li>\n<li>Giardiasis</li>\n<li>Rheumatoid arthritis</li>\n<li>Systemic lupus erythematosus</li>\n<li>Discoid lupus erythematosus</li>\n<li>Porphyria cutanea tarda</li>\n<li>Severe polymorphous light eruption</li>\n</ul>\n</div>\n</div>\n</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB4861",
      "difficulty": "medium"
    },
    {
      "text": "A 26-year-old woman who is 10 weeks pregnant, comes with history of fever and chills. She is diagnosed with falciparum malaria. Which of the following drugs will you choose for her treatment?",
      "choices": [
        {
          "id": 1,
          "text": "Quinine plus clindamycin"
        },
        {
          "id": 2,
          "text": "Quinine plus doxycycline"
        },
        {
          "id": 3,
          "text": "Artemether plus lumefantrine"
        },
        {
          "id": 4,
          "text": "Artesunate plus pyrimethamine-sulfadoxine"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The woman is in the 1<sup>st</sup> trimester of pregnancy and <strong><em>falciparum</em> malaria</strong> during <strong>1<sup>st</sup> trimester</strong> of pregnancy is treated with&nbsp;<strong>quinine plus clindamycin</strong>.</p>\n<p>Worldwide, most species of <em>Falciparum</em> malaria are resistant to chloroquine. In<strong> all trimesters, </strong>pregnant women diagnosed with<strong> uncomplicated malaria </strong>caused by <strong>chloroquine-resistant&nbsp;<em>P. falciparum</em>&nbsp;infection</strong> can be treated with a&nbsp;combination of <strong>quinine and clindamycin</strong><strong>. </strong></p>\n<p><strong>Quinine</strong> is considered the&nbsp;<strong>drug of choice </strong>in the<strong> first trimester.&nbsp;</strong>In&nbsp;the second and third trimesters artemether-lumefantrine can be used, but not in the first trimester.</p>\n<p><strong>Vivax malaria</strong> during<strong> pregnancy</strong> is treated with <strong>chloroquine</strong> as chloroquine is safe in pregnancy and children.</p>\n<p><strong>Clindamycin</strong> can be used in children for chloroquine-resistant cases. It is <strong>safe</strong> to use in<strong> children and pregnant women.</strong></p>\n<p>Option B: Doxycycline is useful in the treatment of malaria but not used in pregnancy.</p>\n<p>Options C and D: Artemisinin-based combination therapy (ACT) is not recommended during the 1st trimester of pregnancy because of a lack of safety data.</p><hr><h3>Related Pearl: Treatment of Malaria</h3><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td>\n<p><strong> Drug of Choice</strong></p>\n</td>\n<td>\n<p><strong>&nbsp;Primaquine Dose</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>P. vivax malaria </strong></p>\n</td>\n<td>\n<p><strong>Chloroquine</strong> 25 mg/kg divided as:</p>\n<p>10mg/kg on day 1</p>\n<p>10mg/kg on day 2</p>\n<p>5mg/kg on day 3</p>\n</td>\n<td>\n<p>0.25 mg/kg for 14 days</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>P. falciparum malaria</strong></p>\n<p>North East</p>\n<p>In other states</p>\n</td>\n<td>\n<p>&nbsp;</p>\n<p><strong>ACT-AL</strong> for 3 days</p>\n<p><strong>ACT-SP</strong> for 3 days&nbsp;</p>\n</td>\n<td>\n<p>&nbsp;</p>\n<p>0.75mg/kg on day 2</p>\n<p>0.75mg/kg on day 2</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Mixed infection</strong></p>\n<p>North East</p>\n<p>In other states</p>\n</td>\n<td>\n<p><strong>ACT-AL</strong> for 3 days</p>\n<p><strong>ACT-SP</strong> for 3 days</p>\n</td>\n<td>\n<p>&nbsp;</p>\n<p>0.25 mg/kg for 14 days</p>\n<p>0.25 mg/kg for 14 days</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Resistance to ACT/ Severe malaria </strong></p>\n</td>\n<td>\n<p>&nbsp;</p>\n<p><strong>Quinine </strong></p>\n</td>\n<td>\n<p>&nbsp;</p>\n<p><strong> -</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Pregnancy</strong></p>\n<p><strong>P. vivax</strong></p>\n</td>\n<td>\n<p><strong>Chloroquine </strong></p>\n</td>\n<td>\n<p><strong>Contraindicated</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Pregnancy</strong></p>\n<p><strong>P. falciparum</strong></p>\n</td>\n<td>\n<p>1<sup>st&nbsp;</sup>trimester: <strong>Quinine</strong></p>\n<p>2<sup>nd</sup> and 3<sup>rd</sup> trimester<strong>: Area specific ACT</strong></p>\n</td>\n<td>\n<p>&nbsp;</p>\n<p><strong>Contraindicated</strong></p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><strong>ACT:&nbsp;</strong>artemisinin-based combination therapy</p>\n<p><strong>AL:</strong>&nbsp;artemether-lumefantrine</p>\n<p><strong>SP</strong>: Sulfadoxine-<wbr />Pyrimethamine</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB4897",
      "difficulty": "medium"
    },
    {
      "text": "A 32-year-old man presents with fever with chills and seizures. On examination, his blood pressure was 70/50 mm of Hg and labored breathing was present. Routine blood investigations revealed Hb of 4.8 g/dl. ABG was done and the pH was 7.21. Findings in peripheral blood smear are shown below. Which of the following is the drug of choice in this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Chloroquine"
        },
        {
          "id": 2,
          "text": "Quinine"
        },
        {
          "id": 3,
          "text": "Artesunate"
        },
        {
          "id": 4,
          "text": "Artemether"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>This scenario depicts a case of <strong>severe complicated falciparum malaria</strong>,<strong>&nbsp;</strong>and the drug of choice in this condition&nbsp;is<strong> artesunate</strong>. The image shows ring forms/early trophozoites in erythrocyte, which are binucleate (double chromatin) and this is characteristic of P. falciparum malaria.</p>\n<p>Severe complicated malaria is caused by P. falciparum and is characterized by hyperparasitemia, hyperpyrexia, <strong>acidosis</strong>, <strong>respiratory distress</strong>, bleeding manifestation, <strong>cardiovascular collapse</strong>, renal failure and cerebral malaria.</p>\n<p>As per WHO guidelines, all patients with severe malaria should be <strong>treated with intravenous or intramuscular artesunate</strong> for at least 24 hours. Once the patient recovers and can tolerate oral medications, oral ACT for 3 days is recommended.</p>\n<p>Artemether is used only if parenteral artesunate is not available.</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/d429b8f0575b4110a136e8742db2c027.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB4893",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is not a WHO recommended artemisinin-based combination therapy?",
      "choices": [
        {
          "id": 1,
          "text": "Artesunate plus amodiaquine"
        },
        {
          "id": 2,
          "text": "Artesunate plus quinine"
        },
        {
          "id": 3,
          "text": "Artesunate plus pyrimethamine-sulfadoxine"
        },
        {
          "id": 4,
          "text": "Artesunate plus mefloquine"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>WHO recommended artemisinin-based combination therapies are:</p>\n<ul>\n<li>Artemether plus lumefantrine</li>\n<li>Artesunate plus pyrimethamine-sulfadoxine</li>\n<li>Artesunate plus mefloquine</li>\n<li>Artesunate plus amodiaquine</li>\n<li>Dihydroartemisinin plus piperaquine</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB4895",
      "difficulty": "medium"
    },
    {
      "text": "You are posted in a health centre in Nagaland as part of your rural service and a patient is diagnosed with uncomplicated falciparum malaria. Which of the following artemisinin-based combination therapy is recommended by NVBDCP for this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Artesunate - sulfadoxine+pyrimethamine"
        },
        {
          "id": 2,
          "text": "Artesunate - chloroquine"
        },
        {
          "id": 3,
          "text": "Artesunate - mefloquine"
        },
        {
          "id": 4,
          "text": "Artemether - lumefantrine"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The artemisinin-based combination therapy (ACT) recommended by NVBDCP in the <strong>north-eastern states</strong> is a combination of <strong>artemether and lumefantrine.</strong></p>\n<p>NVBDCP guidelines for the treatment of uncomplicated falciparum cases:</p>\n<ul>\n<li>North-eastern states:&nbsp;Artemether-lumefantrine based ACT</li>\n<li>Rest of the country:&nbsp;Artesunate-sulfadoxine+pyrimethamine</li>\n</ul>\n<p>In the north-eastern states (Arunachal Pradesh, Assam, Manipur, Meghalaya, Mizoram, Nagaland, and Tripura),&nbsp;the presently recommended ACT for&nbsp;<em>P. falciparum</em> malaria is a fixed-dose combination of artemether-lumefantrine due to the recent reports of late treatment failures with the current combination of AS+SP.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC3731",
      "difficulty": "easy"
    },
    {
      "text": "Loading dose is essential for chloroquine because of which of the following properties?",
      "choices": [
        {
          "id": 1,
          "text": "Undergoes fast hofmann degradation"
        },
        {
          "id": 2,
          "text": "Rapid hepatic elimination"
        },
        {
          "id": 3,
          "text": "High volume of distribution"
        },
        {
          "id": 4,
          "text": "High first-pass metabolism"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Loading dose is essential for <strong>chloroquine</strong> because of its property of <strong>high volume of distribution</strong>.</p>\n<p>Chloroquine is distributed extensively in the liver, spleen, kidney, lungs, skin and, to a lesser extent, brain and spinal cord. Because of <strong>extensive tissue binding</strong>, a loading dose is required for achieving effective plasma concentrations earlier in the therapy.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB4852",
      "difficulty": "medium"
    },
    {
      "text": "While writing a prescription for a patient diagnosed with malaria, the medical officer instructed the patient to take a particular drug along with a high fatty meal. Identify the drug.",
      "choices": [
        {
          "id": 1,
          "text": "Mefloquine"
        },
        {
          "id": 2,
          "text": "Lumefantrine"
        },
        {
          "id": 3,
          "text": "Chloroquine"
        },
        {
          "id": 4,
          "text": "Amodiaquine"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The drug described here is <strong>lumefantrine</strong> and its absorption increases when it is administered along with fatty food or milk because it is highly<strong>&nbsp;lipophilic</strong>.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB4876",
      "difficulty": "medium"
    },
    {
      "text": "A patient who was diagnosed with malaria was initiated on treatment about 3 days ago. Now she presents with seizures and confusion. Which of the following drugs is most likely to have caused this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Artesunate"
        },
        {
          "id": 2,
          "text": "Arteether"
        },
        {
          "id": 3,
          "text": "Lumefantrine"
        },
        {
          "id": 4,
          "text": "Mefloquine"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The case depicts <strong>neuropsychiatric adverse effects</strong> which are commonly associated with the use of <strong>mefloquine</strong>. The US FDA has put a \"black box warning\"<strong>&nbsp;</strong>for this drug&nbsp;due to permanent and serious neuropsychiatric side effects.</p>\n<p>The CNS toxicity caused by mefloquine includes:</p>\n<ul>\n<li>Seizures</li>\n<li>Acute psychosis</li>\n<li>Severe vertigo</li>\n<li>Confusion or decreased sensorium</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB4879",
      "difficulty": "medium"
    },
    {
      "text": "The finding shown in the image below is seen as a side effect of which of the following drugs?<div class='question-desc-html'><ol>\n<li>Chloroquine</li>\n<li>Quinine</li>\n<li>Hydroxychloroquine</li>\n<li>Artesunate</li>\n<li>Lumefantrine</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "1, 4 and 5 only"
        },
        {
          "id": 2,
          "text": "1, 3 and 5 only"
        },
        {
          "id": 3,
          "text": "1 and 3 only"
        },
        {
          "id": 4,
          "text": "2 and 4 only"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The finding shown in the image is<strong> bulls-eye maculopathy,</strong> and<strong> chloroquine and hydroxychloroquine</strong> use are associated with this side effect.</p>\n<p>Bull's-eye maculopathy refers to the ophthalmoscopic appearance of a<strong> central area of retinal pigment epithelial depigmentation</strong> surrounded by relatively normal retinal pigment epithelium, giving a bull's-eye appearance to the macula.</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/05e0376fc11340daa9d74b749ff969d7.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB4884",
      "difficulty": "medium"
    },
    {
      "text": "A pregnant patient with severe malaria is undergoing treatment with quinine. Which of the following adverse effects is not associated with this drug?",
      "choices": [
        {
          "id": 1,
          "text": "Tinnitus"
        },
        {
          "id": 2,
          "text": "Hypoglycemia"
        },
        {
          "id": 3,
          "text": "Hypertension"
        },
        {
          "id": 4,
          "text": "Blackwater fever"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Quinine is not associated with <strong>hypertension</strong>. It is associated with <strong>hypotension</strong>.&nbsp;</p>\n<p>Quinine is used in the treatment of&nbsp;drug-resistant and severe P. falciparum malaria. It acts against asexual erythrocytic forms but has no significant effect on hepatic forms of malarial parasites.&nbsp;</p>\n<p>Option A: Quinine use is associated with <strong>cinchonism</strong> which manifests as tinnitus, visual and auditory disturbances, headache, nausea, and vomiting.&nbsp;</p>\n<p>Option B:&nbsp;Quinine has a stimulatory effect on pancreatic beta cells and can cause <strong>hypoglycemia.</strong></p>\n<p>Option D: <strong>Blackwater fever</strong> is a rare type of <strong>hypersensitivity reaction</strong> to quinine. It presents with&nbsp;massive hemolysis, hemoglobinemia, and hemoglobinuria that may lead to anuria, renal failure, and death.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB4888",
      "difficulty": "medium"
    },
    {
      "text": "A patient who was initiated on treatment for malaria two days ago, now presents with complaints of passage of dark-colored urine. Hemolysis due to G6PD deficiency is suspected. With which of the following drugs is this condition more common?",
      "choices": [
        {
          "id": 1,
          "text": "Quinine"
        },
        {
          "id": 2,
          "text": "Chloroquine"
        },
        {
          "id": 3,
          "text": "Hydroxychloroquine"
        },
        {
          "id": 4,
          "text": "Primaquine"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Hemolysis in a G6PD deficient patient is more common with <strong>primaquine</strong>.</p>\n<p>G6PD deficient patients are highly sensitive to oxidative stress. They are at <strong>increased risk of hemolysis</strong> due to&nbsp;the oxidant property of primaquine. Therefore, before initiating primaquine therapy, the G6PD status of the patient has to be determined. Passage of dark color urine is an indication of hemolysis and the drug has to be stopped if it occurs.</p>\n<p>Quinine, chloroquine and hydroxychloroquine can also cause hemolysis in G6PD deficient patients, but the incidence is&nbsp;less compared to&nbsp;primaquine.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB4891",
      "difficulty": "medium"
    }
  ]
}